代谢重编程,线粒体损伤和在增殖性玻璃红蛋白病变中的类固醇反应之间的相互作用
Xinyuan Huang1, Qingbo Li1, Manhong Xu1
1Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, PR China, No.251 Fu Kang Road, Nankai District, Tianjin, 300384, PR China.
Free radical biology & medicine
|January 18, 2025
概括
对于增殖性玻璃色素变异症 (PVR) 的类固醇治疗在早期可能更有效. 这项研究将PVR与代谢变化和线粒体功能障碍联系起来,这表明时间对德克萨米他的有效性至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 增殖性玻璃视网膜病变 (PVR) 是视网膜脱落修复失败的主要原因.
- 目前用于PVR的药物疗法缺乏经过证明的有效性,并且类固醇疗效仍然不确定.
- 不被理解的机制可能是PVR病原体和类固醇不响应的基础.
研究的目的:
- 研究代谢重编程和线粒体功能障碍在PVR中的作用.
- 探索这些细胞变化与类固醇治疗 (德甲) 的有效性之间的关联.
主要方法:
- 来自PVR患者的玻璃体样本的蛋白质组分析.
- 对PVR组织和细胞模型 (RPE细胞) 的转录基因分析.
- 在体内研究中,使用小鼠PVR模型和静脉内甲松注射.
主要成果:
- PVR与葡萄糖分解增加和氧化酸化 (OXPHOS) 和线粒体功能降低有关.
- 在长期暴露的细胞模型中,甲反应途径被降低了.
- 在小鼠模型中,早期的甲干预减轻了PVR的严重程度,而后来的干预效果不那么好.
结论:
- 代谢重编程和线粒体功能障碍是PVR病理学的关键因素.
- 类固醇在PVR中的有效性可能取决于阶段,可能有利于早期干预.
- 类固醇治疗的时间对于管理PVR和改善治疗结果至关重要.
更多相关视频
相关概念视频
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


